Colorectal Cancer Clinical Trials

Showing 1201-1220 of 1,434 trials

Effect of G17DT in Patients With Stage II/III Colorectal Cancer

NCT02518373

This Phase 2 study was an open label, single-center 18-week study to compare basal and meal stimulated plasma gastrin levels before and after treatment with 3 intramuscular injections of 250 µg G17DT, with and without the concomitant administration of Omeprazole.

Colorectal Cancer

Cancer Advances Inc.22 participantsStarted Apr 2000

TERMINATEDNA

Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery

NCT01062919

This is a double blinded randomized controlled trial in patients undergoing colon open surgery. The purpose is to evaluate the effectiveness of two different analgesic techniques on functional recovery after surgery. Twenty five patients will receive thoracic epidural analgesia plus patient controlled analgesia (PCA) (epidural analgesia group) and 25 patients wound infiltration of local anesthetic plus PCA (wound infusion group). Hypothesis: the postoperative recovery of patients receiving local anesthetic wound infusion will be faster than patients receiving thoracic epidural analgesia. Functional recovery, pain intensity, opioid consumption and side effects, length of hospital stay and biological markers of inflammation after surgery will be measured in both groups.

Colon CancerInflammatory Bowel DiseasesDiverticulitis

Franco Carli10 participantsStarted Jul 2009

Montreal, Quebec, Canada • Montreal, Quebec, Canada

Effect of G17DT in Patients With Stage II/III Colorectal Cancer

Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery

Related Searches

Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

Study of Vaginal Dilator Use After Pelvic Radiotherapy

Cancer Mortality Affected by the Choice of Anesthetic Drugs?

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Neoadjuvant Treatment of Colon Cancer

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients